Increased ErbB3 and EGFR activity mediate lapatinib resistance in prostate cancer

被引：0
|
作者：
Jathal, Maitreyee K. [1 ]
Steele, Thomas M. [2 ]
Mooso, Benjamin A. [2 ]
D'Abronzo, Leandro S. [1 ]
Siddiqui, Salma [2 ]
Drake, Christiana [1 ]
Ghosh, Paramita M. [1 ]
机构：
[1] Univ Calif Davis, Davis, CA USA
[2] VA Med Ctr, Sacramento, CA USA
来源：
CANCER RESEARCH | 2014年 / 74卷 / 19期
关键词：
D O I：
10.1158/1538-7445.AM2014-3335
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
3335
引用
收藏
页数：1
相关论文
共 50 条
  • [41] ENHANCED ERBB3 SIGNALING PROMOTES RESISTANCE IN MELANOMA
    不详
    CANCER DISCOVERY, 2013, 3 (05) : 479 - 479
  • [42] MET amplification leads to gefitinib resistance in lung cancer by activating ERBB3 signaling
    Engelman, Jeffrey A.
    Zejnullahu, Kreshnik
    Mitsudomi, Tetsuya
    Song, Youngchul
    Hyland, Courtney
    Park, Joon Oh
    Lindeman, Neal
    Gale, Christopher-Michael
    Zhao, Xiaojun
    Christensen, James
    Kosaka, Takayuki
    Holmes, Alison J.
    Rogers, Andrew M.
    Cappuzzo, Federico
    Mok, Tony
    Lee, Charles
    Johnson, Bruce E.
    Cantley, Lewis C.
    Janne, Pasi A.
    SCIENCE, 2007, 316 (5827) : 1039 - 1043
  • [43] ERBB3 enhances ERBB2 activation leading to increased cell motility and invasion in bladder cancer cells
    Kotwal, Sanjeev
    Tomlinson, Darren
    Pitt, Eva
    Paul, Alan
    Knowles, Margaret
    CANCER RESEARCH, 2009, 69
  • [44] HIGHER EXPRESSION OF ERBB3 PROMOTES INCREASED RESPONSIVENESS TO ANDROGEN RECEPTOR AND MTOR INHIBITION IN PATIENTS WITH CASTRATION-RESISTANT PROSTATE CANCER
    Eke, Bebe
    Ghosh, Paramita
    JOURNAL OF UROLOGY, 2024, 211 (05): : E1002 - E1002
  • [45] Bone microenvironment and androgen status modulate subcellular localization of ErbB3 in prostate cancer cells
    Cheng, Chien-Jui
    Ye, Xiang-Cang
    Vakar-Lopez, Funda
    Kim, Jeri
    Tu, Shi-Ming
    Chen, Dung-Tsa
    Navone, Nora M.
    Yu-Lee, Li-Yuan
    Lin, Sue-Hwa
    Hu, Mickey C-T.
    MOLECULAR CANCER RESEARCH, 2007, 5 (07) : 675 - 684
  • [46] Characterization of human breast cancer cells with acquired resistance to the EGFR/ErbB-2 tyrosine kinase inhibitor lapatinib
    De Luca, Antonella
    Faraso, Stefania
    D'Alessio, Amelia
    Gallo, Marianna
    Lamura, Luana
    Maiello, Monica R.
    Normanno, Nicola
    CANCER RESEARCH, 2011, 71
  • [47] A 45-kDa ErbB3 secreted by prostate cancer cells promotes bone formation
    S-H Lin
    C-J Cheng
    Y-C Lee
    X Ye
    W-W Tsai
    J Kim
    R Pasqualini
    W Arap
    N M Navone
    S-M Tu
    M Hu
    L-Y Yu-Lee
    C J Logothetis
    Oncogene, 2008, 27 : 5195 - 5203
  • [48] A 45-kDa ErbB3 secreted by prostate cancer cells promotes bone formation
    Lin, S-H
    Cheng, C-J
    Lee, Y-C
    Ye, X.
    Tsai, W-W
    Kim, J.
    Pasqualini, R.
    Arap, W.
    Navone, N. M.
    Tu, S-M
    Hu, M.
    Yu-Lee, L-Y
    Logothetis, C. J.
    ONCOGENE, 2008, 27 (39) : 5195 - 5203
  • [49] Essential function for ErbB3 in breast cancer proliferation
    Elena Perez-Nadales
    Alison C Lloyd
    Breast Cancer Research, 6
  • [50] Induction of erbB3/EGFR heterodimers mediates resistance to pertuzumab in a tamoxifen-resistant MCF-7 breast cancer cell line
    Hutcheson, Lain R.
    Barrow, Denise
    Hasmann, Max
    Nicholson, Robert I.
    MOLECULAR CANCER THERAPEUTICS, 2007, 6 (12) : 3373S - 3373S
12345